Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women (Q28217820)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: July 2007)
edit
Language Label Description Also known as
English
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women
scientific article (publication date: July 2007)

    Statements

    Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Hideaki Yahata
    0 references
    Ikuo Konishi
    0 references
    Toshiharu Yasugi
    0 references
    Toru Nakanishi
    0 references
    Hiroshi Sasaki
    0 references
    Fumitaka Saji
    0 references
    Tsuyoshi Iwasaka
    0 references
    Masayuki Hatae
    0 references
    Shoji Kodama
    0 references
    Tsuyoshi Saito
    0 references
    Masamichi Hiura
    0 references
    Atsuhiko Sakamoto
    0 references
    Masaharu Fukunaga
    0 references
    1 July 2007
    0 references
    25
    0 references
    2798-803
    0 references
    19
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit